Miyaoka, D., Tsuda, A., Hayashi, N., Toi, N., Yamasaki, A., Nagata, Y., . . . Inaba, M. (2017). Development of hyperkalemia following treatment with dapagliflozin (DAPA) in a patient with type 2 diabetes after bilateral adrenalectomy. CEN Case Rep.
Style de citation ChicagoMiyaoka, Daichi, et al. "Development of Hyperkalemia Following Treatment With Dapagliflozin (DAPA) in a Patient With Type 2 Diabetes After Bilateral Adrenalectomy." CEN Case Rep 2017.
Style de citation MLAMiyaoka, Daichi, et al. "Development of Hyperkalemia Following Treatment With Dapagliflozin (DAPA) in a Patient With Type 2 Diabetes After Bilateral Adrenalectomy." CEN Case Rep 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.